Status:
TERMINATED
Remicade® Crohn's Disease Registry Across Canada (Study P02793)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Crohn's Disease
Eligibility:
All Genders
Brief Summary
This registry is a multi-center, prospective, observational program that will gather and analyze data on subjects with Crohn's disease being treated with Remicade® as per approved product monograph in...
Detailed Description
Subjects will be selected for this registry using a non-probability sampling method.
Eligibility Criteria
Inclusion
- Patient was given the Patient Information Brochure; AND,
- Patient has never been treated with Remicade® (patient is naïve to Remicade® at the time of registration); AND,
- Patient is a good candidate to receive Remicade® as per the product monograph; AND,
- Patient has agreed to complete the Patient Diary for one week prior to each visit in the registry; AND,
- Patient has signed the approved consent form.
Exclusion
- Per product monograph
Key Trial Info
Start Date :
February 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
556 Patients enrolled
Trial Details
Trial ID
NCT00755937
Start Date
February 1 2002
End Date
September 1 2007
Last Update
June 22 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.